What do you do after you have launched a spinout that has raised venture capital from illustrious backers such as pharmaceutical firm Novo, care provider Kaiser Permanente and medical device manufacturer St Jude Medical, and successfully gone public through a $107m initial public offering?

A host of corporate and government-backed initiatives have been launched to tackle the coronavirus that develops into the Covid-19 disease. In a global, fast-moving pandemic, this can only be a snapshot of the efforts at the end of March 2020.

Mental health treatment app provider SilverCloud Health has now raised more than $30m, having spun out of Trinity College Dublin in 2012.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Tsinghua-run incubator Lotus Lake Capital has backed Insight Lifetech, which develops treatment and diagnostic tools for coronary heart disease.

The SiBionics-backed heart disease device developer secured $28.4m in a round led by SDIC Gaoxin Industrial Investment.

Princeton University is a long-standing partner of Qiming Venture Partners, having invested in the latter's inaugural fund back in 2006.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Deerfield's second Healthcare Innovations Fund is one and a half times larger than its predecessor and will align with more than 15 university ecosystems.